Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy
出版年份 2023 全文链接
标题
Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy
作者
关键词
-
出版物
LANCET NEUROLOGY
Volume 22, Issue 4, Pages 338-349
出版商
Elsevier BV
发表日期
2023-02-08
DOI
10.1016/s1474-4422(22)00471-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM
- (2022) Tobias V. Lanz et al. NATURE
- Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
- (2022) Kjetil Bjornevik et al. SCIENCE
- BTK inhibition limits B-cell–T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy
- (2022) Rui Li et al. ACTA NEUROPATHOLOGICA
- Single-cell multiomics in neuroinflammation
- (2022) Florian Ingelfinger et al. CURRENT OPINION IN IMMUNOLOGY
- Multiple sclerosis: two decades of progress
- (2022) Bruce A C Cree et al. LANCET NEUROLOGY
- A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice
- (2022) Chih-Jen Wei et al. Science Translational Medicine
- From the prodromal stage of multiple sclerosis to disease prevention
- (2022) Ruth Ann Marrie et al. Nature Reviews Neurology
- PD-1/PD-L Axis in Neuroinflammation: New Insights
- (2022) Susanna Manenti et al. Frontiers in Neurology
- The Potential for EBV Vaccines to Prevent Multiple Sclerosis
- (2022) Peter A. Maple et al. Frontiers in Neurology
- Epstein-Barr virus: Biology and clinical disease
- (2022) Blossom Damania et al. CELL
- Broader Epstein–Barr virus–specific T cell receptor repertoire in patients with multiple sclerosis
- (2022) Tilman Schneider-Hohendorf et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genetics of multiple sclerosis: lessons from polygenicity
- (2022) An Goris et al. LANCET NEUROLOGY
- Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study
- (2022) Robert Zivadinov et al. Multiple Sclerosis and Related Disorders
- Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study
- (2022) María Inmaculada Domínguez-Mozo et al. Frontiers in Immunology
- A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism
- (2021) R. Jason Lamontagne et al. PLoS Pathogens
- MS is rare in EBV ‐seronegative children with CNS inflammatory demyelination
- (2021) Bardia Nourbakhsh et al. ANNALS OF NEUROLOGY
- Trained Immunity: Reprogramming Innate Immunity in Health and Disease
- (2021) Siroon Bekkering et al. Annual Review of Immunology
- Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy
- (2021) Zara A. Ioannides et al. Frontiers in Neurology
- Identification of Potential Inhibitors against Epstein–Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations
- (2021) Shweta Jakhmola et al. ACS Chemical Neuroscience
- Bruton's tyrosine kinase inhibition in the treatment of preclinical models and multiple sclerosis
- (2021) Anja Steinmaurer et al. CURRENT PHARMACEUTICAL DESIGN
- HLA‐DRB1*15:01 is a co‐receptor for Epstein–Barr virus, linking genetic and environmental risk factors for multiple sclerosis
- (2021) Jennifer Menegatti et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- BTK inhibitors as potential therapies for multiple sclerosis
- (2021) Jorge Correale LANCET NEUROLOGY
- B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies
- (2021) Maria T. Cencioni et al. Nature Reviews Neurology
- Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes
- (2021) Samantha S. Soldan et al. PLoS Pathogens
- The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
- (2021) Caterina Veroni et al. Frontiers in Immunology
- The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype
- (2021) Jeremy Thomas Keane et al. EBioMedicine
- Epstein–Barr virus nuclear antigen 2 extensively rewires the human chromatin landscape at autoimmune risk loci
- (2021) Ted Hong et al. GENOME RESEARCH
- Follow-up after infectious mononucleosis in search of serological similarities with presymptomatic multiple sclerosis
- (2021) Daniel Jons et al. Multiple Sclerosis and Related Disorders
- The cellular immune response against Epstein-Barr virus decreases during ocrelizumab treatment
- (2021) H.Phuong T. Pham et al. Multiple Sclerosis and Related Disorders
- Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis
- (2021) Ute-Christiane Meier et al. Frontiers in Immunology
- Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
- (2021) Xinle Cui et al. Frontiers in Immunology
- Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis
- (2020) Rosella Mechelli et al. Genes
- High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk
- (2020) Anna Karin Hedström et al. Frontiers in Neurology
- Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis
- (2020) Sargis Abrahamyan et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Systematic review and meta-analysis of the association between Epstein–Barr virus, multiple sclerosis and other risk factors
- (2020) Benjamin M Jacobs et al. Multiple Sclerosis Journal
- HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis
- (2020) Jian Wang et al. CELL
- Attenuated immune control of Epstein Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15
- (2020) Hana Zdimerova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension
- (2020) Joakim Bergman et al. JOURNAL OF NEUROLOGY
- PRF1 mutation alters immune system activation, inflammation, and risk of autoimmunity
- (2020) Carlo Sidore et al. Multiple Sclerosis Journal
- EBV-specific CD8 T lymphocytes and B cells during glatiramer acetate therapy in patients with MS
- (2020) Gisella Guerrera et al. Neurology-Neuroimmunology & Neuroinflammation
- The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review
- (2020) Klemens Ruprecht Expert Review of Clinical Immunology
- Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology
- (2020) Anna Karin Hedström et al. Neurology-Neuroimmunology & Neuroinflammation
- Cytotoxicity in Epstein Barr virus specific immune control
- (2020) Christian Münz Current Opinion in Virology
- Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth
- (2019) Troy E. Messick et al. Science Translational Medicine
- Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells
- (2019) Wei Bu et al. IMMUNITY
- Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors
- (2019) Jonathan R Kerr JOURNAL OF CLINICAL PATHOLOGY
- Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk
- (2019) Katarina Tengvall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
- (2019) SCIENCE
- Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism
- (2019) Barbara Serafini et al. JOURNAL OF VIROLOGY
- The promise of a prophylactic Epstein–Barr virus vaccine
- (2019) Henry H. Balfour et al. PEDIATRIC RESEARCH
- Teriflunomide's effect on humoral response to Epstein-Barr virus and development of cortical gray matter pathology in multiple sclerosis
- (2019) Robert Zivadinov et al. Multiple Sclerosis and Related Disorders
- Epstein-Barr virus-associated immune reconstitution inflammatory syndrome as possible cause of fulminant multiple sclerosis relapse after natalizumab interruption
- (2018) Barbara Serafini et al. JOURNAL OF NEUROIMMUNOLOGY
- Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity
- (2018) John B. Harley et al. NATURE GENETICS
- Reassessing B cell contributions in multiple sclerosis
- (2018) Rui Li et al. NATURE IMMUNOLOGY
- Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells
- (2018) Asma Hassani et al. PLoS One
- Antiviral Drugs for EBV
- (2018) Joseph Pagano et al. Cancers
- Sequence variation of Epstein-Barr virus: viral types, geography, codon usage and diseases
- (2018) Samantha Correia et al. JOURNAL OF VIROLOGY
- Bridging the gap between vaccination with Bacille Calmette-Guérin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis
- (2018) Giovanni Ristori et al. CURRENT OPINION IN IMMUNOLOGY
- Massive intracerebral Epstein-Barr virus reactivation in lethal multiple sclerosis relapse after natalizumab withdrawal
- (2017) Barbara Serafini et al. JOURNAL OF NEUROIMMUNOLOGY
- Drug Modulators of B Cell Signaling Pathways and Epstein-Barr Virus Lytic Activation
- (2017) John G. Kosowicz et al. JOURNAL OF VIROLOGY
- Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
- (2017) Andrea Bilger et al. Oncotarget
- Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis
- (2017) René M. Gieß et al. PLoS One
- Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis
- (2017) Sundararajan Srinivasan et al. Scientific Reports
- Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis
- (2016) Fabiana Rizzo et al. IMMUNOLOGY AND CELL BIOLOGY
- Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
- (2016) Tomas Olsson et al. Nature Reviews Neurology
- Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
- (2016) Mika Komori et al. Annals of Clinical and Translational Neurology
- Antivirus immune activity in multiple sclerosis correlates with MRI activity
- (2015) L. B. Latham et al. ACTA NEUROLOGICA SCANDINAVICA
- Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins
- (2015) Gijsbert P van Nierop et al. Multiple Sclerosis Journal
- Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination
- (2015) Naila Makhani et al. Multiple Sclerosis Journal
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
- (2015) J Kuhle et al. Multiple Sclerosis Journal
- Epstein-Barr virus genetic variants are associated with multiple sclerosis
- (2015) R. Mechelli et al. NEUROLOGY
- No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT
- (2015) Kassandra L. Munger et al. NEUROLOGY
- Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins
- (2015) Gijsbert P van Nierop et al. Multiple Sclerosis Journal
- Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination
- (2015) Naila Makhani et al. Multiple Sclerosis Journal
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
- (2015) J Kuhle et al. Multiple Sclerosis Journal
- EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy
- (2015) Vito A. G. Ricigliano et al. PLoS One
- High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+T cells
- (2014) Andreas Lossius et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Quantitative Detection of Epstein-Barr Virus DNA in Cerebrospinal Fluid and Blood Samples of Patients with Relapsing-Remitting Multiple Sclerosis
- (2014) Clementina E. Cocuzza et al. PLoS One
- Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
- (2014) A. Palanichamy et al. Science Translational Medicine
- B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
- (2014) J. N. H. Stern et al. Science Translational Medicine
- Multiple sclerosis therapy and Epstein–Barr virus antibody titres
- (2014) Joel Raffel et al. Multiple Sclerosis and Related Disorders
- Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
- (2013) Daniela F. Angelini et al. PLoS Pathogens
- Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria
- (2011) H. Lassmann et al. BRAIN
- Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel
- (2011) KL Munger et al. Multiple Sclerosis Journal
- Intrathecal immune responses to EBV in early MS
- (2009) Emilie Jaquiéry et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
- (2008) Samantha Jilek et al. BRAIN
- EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
- (2008) Jan D. Lünemann et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now